Yufan Ying

1.5k total citations
30 papers, 953 citations indexed

About

Yufan Ying is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yufan Ying has authored 30 papers receiving a total of 953 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 15 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yufan Ying's work include RNA modifications and cancer (12 papers), Cancer-related molecular mechanisms research (11 papers) and Cancer-related gene regulation (8 papers). Yufan Ying is often cited by papers focused on RNA modifications and cancer (12 papers), Cancer-related molecular mechanisms research (11 papers) and Cancer-related gene regulation (8 papers). Yufan Ying collaborates with scholars based in China and United States. Yufan Ying's co-authors include Jiangfeng Li, Haiyun Xie, Xiangyi Zheng, Liping Xie, Xiao Wang, Huaqing Yan, Xin Xu, Liujia He, Xueyou Ma and Ben Liu and has published in prestigious journals such as The FASEB Journal, Molecular Cancer and Cell Reports.

In The Last Decade

Yufan Ying

27 papers receiving 950 citations

Peers

Yufan Ying

PRM

ONCOL

SURGE

Haiyun Xie China

Ruiyan Wu China

Zirui He China

Xueyou Ma China

Jianfeng Sang China

Botai Li China

R. Tang Taiwan

Samir Ounzain Switzerland

Jia Xiong China

Haiyun Xie China

Yufan Ying

953 ×1.2

575 ×1.2

101 ×0.7

PRM

97 ×0.9

ONCOL

90 ×1.0

SURGE

Citations per year, relative to Yufan Ying Yufan Ying (= 1×) peers Haiyun Xie

Countries citing papers authored by Yufan Ying

Since Specialization

Citations

This map shows the geographic impact of Yufan Ying's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yufan Ying with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yufan Ying more than expected).

Fields of papers citing papers by Yufan Ying

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yufan Ying. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yufan Ying. The network helps show where Yufan Ying may publish in the future.

Co-authorship network of co-authors of Yufan Ying

This figure shows the co-authorship network connecting the top 25 collaborators of Yufan Ying. A scholar is included among the top collaborators of Yufan Ying based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yufan Ying. Yufan Ying is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Jiaming, Haiyun Xie, Zixiang Liu, et al.. (2025). KIF26B promotes bladder cancer progression via activating Wnt/β-catenin signaling in a TRAF2-dependent pathway. Cell Reports. 44(5). 115595–115595.

Ying, Yufan, Xueyou Ma, Yuqing Wu, et al.. (2025). SREBF1-mediated SND1 transcriptional activation promotes prostate cancer progression via MTDH interaction through the SESN2/AMPK/mTOR axis. Journal of Translational Medicine. 23(1). 885–885.

Wu, Yuqing, Yufan Ying, Fenghao Zhang, et al.. (2024). NSUN2-mediated R-loop stabilization as a key driver of bladder cancer progression and cisplatin sensitivity. Cancer Letters. 611. 217416–217416. 4 indexed citations

Shu, Xuan, Jiaming Wang, Wen Cai, et al.. (2024). Clinical assessment of urinary prostate cancer antigen 3 in Chinese population: a large-scale, prospective and multicenter study. World Journal of Surgical Oncology. 22(1). 355–355.

Shu, Xuan, Jiangfeng Li, Yufan Ying, et al.. (2024). N6-methyladenosine-modified circRPS6KC1 regulated cellular senescence in prostate cancer via FOXM1/PCNA axis. Cellular Signalling. 125. 111510–111510. 8 indexed citations

Ma, Xueyou, Yufan Ying, Xuan Shu, et al.. (2024). N6-methyladenosine-modified CircPSMA7 enhances bladder cancer malignancy through the miR-128–3p/MAPK1 axis. Cancer Letters. 585. 216613–216613. 14 indexed citations

Shen, Haixiang, Yufan Ying, Xueyou Ma, et al.. (2022). FTO promotes clear cell renal cell carcinoma progression via upregulation of PDK1 through an m6A dependent pathway. Cell Death Discovery. 8(1). 356–356. 14 indexed citations

Ma, Xueyou, Yufan Ying, Weiyu Wang, et al.. (2022). SMAD3 and FTO are involved in miR-5581-3p-mediated inhibition of cell migration and proliferation in bladder cancer. Cell Death Discovery. 8(1). 199–199. 13 indexed citations

Ying, Yufan, Xueyou Ma, Weiyu Wang, et al.. (2021). EGR2-mediated regulation of m6A reader IGF2BP proteins drive RCC tumorigenesis and metastasis via enhancing S1PR3 mRNA stabilization. Cell Death and Disease. 12(8). 750–750. 62 indexed citations

10.

Wang, Song, Xueyou Ma, Yufan Ying, et al.. (2021). Upregulation of ARNTL2 is associated with poor survival and immune infiltration in clear cell renal cell carcinoma. Cancer Cell International. 21(1). 341–341. 21 indexed citations

11.

Ma, Xueyou, Yufan Ying, Haiyun Xie, et al.. (2021). circKDM4C enhances bladder cancer invasion and metastasis through miR-200bc-3p/ZEB1 axis. Cell Death Discovery. 7(1). 365–365. 20 indexed citations

12.

Ma, Xueyou, Yufan Ying, Haiyun Xie, et al.. (2021). The Regulatory Role of RNA Metabolism Regulator TDP-43 in Human Cancer. Frontiers in Oncology. 11. 755096–755096. 19 indexed citations

13.

He, Liujia, Yufan Ying, Haiyun Xie, et al.. (2021). MicroRNA‐501‐3p inhibits the proliferation of kidney cancer cells by targeting WTAP. Cancer Medicine. 10(20). 7222–7232. 24 indexed citations

14.

Xie, Haiyun, Jiangfeng Li, Yufan Ying, et al.. (2020). METTL3/YTHDF2 m ⁶ A axis promotes tumorigenesis by degrading SETD7 and KLF4 mRNAs in bladder cancer. Journal of Cellular and Molecular Medicine. 24(7). 4092–4104. 114 indexed citations

15.

Li, Jiangfeng, Haiyun Xie, Yufan Ying, et al.. (2020). YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer. Molecular Cancer. 19(1). 152–152. 227 indexed citations

16.

Li, Jiangfeng, Haixiang Shen, Haiyun Xie, et al.. (2019). Dysregulation of ncRNAs located at the DLK1-DIO3 imprinted domain: involvement in urological cancers. Cancer Management and Research. Volume 11. 777–787. 21 indexed citations

17.

Yan, Huaqing, Jiangfeng Li, Yufan Ying, et al.. (2018). MIR-300 in the imprinted DLK1-DIO3 domain suppresses the migration of bladder cancer by regulating the SP1/MMP9 pathway. Cell Cycle. 17(24). 2790–2801. 22 indexed citations

18.

Yan, Huaqing, Haiyun Xie, Yufan Ying, et al.. (2018). Pioglitazone use in patients with diabetes and risk of bladder cancer: a systematic review and meta-analysis. Cancer Management and Research. Volume 10. 1627–1638. 26 indexed citations

19.

Yan, Huaqing, Yufan Ying, Haiyun Xie, et al.. (2018). Secondhand smoking increases bladder cancer risk in nonsmoking population: a meta-analysis. Cancer Management and Research. Volume 10. 3781–3791. 27 indexed citations

20.

Li, Jiangfeng, Yufan Ying, Haiyun Xie, et al.. (2018). Dual regulatory role of CCNA2 in modulating CDK6 and MET‐mediated cell‐cycle pathway and EMT progression is blocked by miR‐381‐3p in bladder cancer. The FASEB Journal. 33(1). 1374–1388. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact